◼ Archived
Business
Roche Drug Candidate Hits Target in Late-Stage Study for Autoimmune Disease
Roche's experimental drug sefaxersen meets its primary endpoint in a late-stage study for the autoimmune disease IgAN.
5 trends tracked about this subject — the full history, oldest to newest below.
Roche's experimental drug sefaxersen meets its primary endpoint in a late-stage study for the autoimmune disease IgAN.
1 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Sports story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Minecraft 26.2 introduces 'Chaos Cubed' and shuts down Hardcore mode exploits—what’s next for testers?